AX
Axsome
AXSM·NASDAQNew York NYFounded 2012600 employees
Mid CapbiotechPublicCNS
Platform: Multi-CNS
Market Cap
$5B
All Drugs
3
Clinical Trials
5
Failed / Terminated
3
FDA Approved
0
Stock Price & Catalysts (AXSM)
Loading AXSM stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Elralucimab | AXS-7093 | Phase 2 | 2 | CDK4/6 | Heart FailureEpilepsy | ||
| AXS-4984 | AXS-4984 | Preclinical | 1 | JAK2 | CFCKD | ||
| Doxazasiran | AXS-6481 | Phase 1 | 2 | TIM-3 | BCCPTSD |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)